A potential for the navigation PC SPC-1 component to stop working which could result in potential harms associated with this failure.
Continue reading...20. November 2009
Comments Off
FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest, or death) than patients using a placebo.
Continue reading...19. November 2009
Comments Off
Defective components may cause affected devices to not deliver electric shocks, and the device's self-test may not detect the defect in advance of use.
Continue reading...19. November 2009
Comments Off
Product found containing the bacteria B. cepacia.
Continue reading...18. November 2009
Comments Off
Recall of product, sold as a dietary supplement, containing undeclared sulfoaildenafil.
Continue reading...17. November 2009
Comments Off
Nationwide recall due to stretching or fracture of the sheath during use.
Continue reading...17. November 2009
Comments Off
Five products marketed as dietary supplements contain undeclared substances considered to be steroids.
Continue reading...17. November 2009
Comments Off
Effectiveness of clopidogrel is reduced when taken with omeprazole, placing patients who use clopidogrel to prevent blood clots at risk for heart attacks or strokes if they are also taking omeprazole.
Continue reading...13. November 2009
Comments Off
Weight loss product contains undeclared drug ingredients sibutramine and phenolphthalein.
Continue reading...13. November 2009
Comments Off
Reports of chondrolysis in patients given continuous intra-articular infusions of local anesthetics with elastomeric infusion devices.
Continue reading...
27. November 2009
Comments Off